Connecting for innovation and impact for all in global health
- This event has passed.
JPM 2026 | From Products to Patients: Capturing Value in Asia’s Growth Markets
January 14 @ 3:45 pm - 4:25 pm
At the J.P. Morgan Healthcare Conference 2026 in San Francisco, the Alliance will convene another strategic panel, From Products to Patients: Capturing Value in Asia’s Growth Markets, bringing together Gilead Sciences’ SVP of Emerging Markets, the head of U.S. DFC’s global health investments, and the CEOs of reach52 and Nivi, Inc. to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia.
Please save the date for January 14, 2026 at 3:45 PM PT. While in-person attendance is available only for official JPM 2026 registrants, please complete this form if you are interested in receiving the link to listen to the panel discussion via JPM audio webcast.
A post-JPM panel reception will follow, offering a continuation of the conversation and networking opportunities on January 14, 2026 from 4:30-6:30pm PT. Register here.
Learn more about the Alliance’s financing and investing work, and find insights from our JPM 2024 and 2025 panels here.